Status:
COMPLETED
Study Of Patients With Allergic Rhinitis And Asthma
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
15+ years
Phase:
PHASE4
Brief Summary
This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study ...
Detailed Description
A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD versus Montelu...
Eligibility Criteria
Inclusion
- Have asthma for at least 3 months prior to the study.
- Have been using an allowed pre-study asthma therapy for at least 3 months prior to study.
- Currently have seasonal allergic rhinitis and have had seasonal onset of allergic rhinitis for at least the two previous allergy seasons.
- Have a positive allergy skin test.
Exclusion
- Have a history of life-threatening asthma.
- Been hospitalized for asthma within the 6 months prior to the study.
- Have certain conditions that would make study participation unsafe.
- The study doctor will evaluate other inclusion and exclusion criteria.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00296530
Start Date
September 1 2005
End Date
July 1 2007
Last Update
October 28 2016
Active Locations (80)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Ozark, Alabama, United States, 36360
2
GSK Investigational Site
Tempe, Arizona, United States, 85282
3
GSK Investigational Site
Little Rock, Arkansas, United States, 72205
4
GSK Investigational Site
Fountain Valley, California, United States, 92708